The present disclosure relates to a pharmaceutical composition comprising as active substance betahistine or a pharmaceutically acceptable salt thereof, for use in the treatment of otological or neurological disorders in a human subject by intranasal application.
本公开涉及一种药物组合物,其活性物质包括
倍他司汀或其药学上可接受的盐,用于通过鼻内施用治疗人的耳科或神经系统疾病。